FDA Rejects Psychedelic Drug MDMA As Treatment for PTSD
The potential for psychedelic drugs to serve legitimate medical purposes has become a growing topic of discussion. On August 9, the Food and Drug Administration rejected midomafetamine (MDMA), better known as ecstasy, as a treatment for post-traumatic stress disorder....
MedBen Closed September 2 in Observance of Labor Day
MedBen will be closed on Monday, September 2 in observance of Labor Day. We will reopen at 8:00 a.m. EDT Tuesday, September 3. Even when we’re closed, MedBen Access stays open. You can find fast answers for your claims and benefits questions by going to our online...
Primary Care Focus Beneficial to Specialists, Too
As we frequently emphasize here, building a professional relationship with a primary care physician helps them to detect and prevent chronic conditions as early as possible... indeed, this proactive strategy lies at the heart of our MedBen WellLiving program. But...
Looking for Plan Resources? Head to MedBen.com!
Next time you go to MedBen.com, we encourage you to spend a few minutes in the Resources area. There, you'll find a number of tools that helps administrators and members better manage their plan, including: Online Services – Links to MedBen sites that provide a...
Employers Continue to Rank Health Care as Most Important Employee Benefit
Employers continue to rank health care highest in importance of employee benefits, according to the 2024 SHRM Employee Benefits Survey. As shown in the graph below, 88% of respondents said they consider health care-related benefits to be “extremely important” or “very...
Greater Biosimilar Use Could Save U.S. $133 Billion in 2025
From a STAT opinion piece by Juliana M. Reed, executive director of the Biosimilars Forum: "Biologic medicines are some of the most important drugs in the world. They are also among the most expensive. Biosimilars are FDA-approved treatments that are similar to...
Blood Test to Determine Colon Cancer Gets FDA Approval
On July 29, the Food and Drug Administration approved a first-of-its-kind blood test determined to be 83% effective at detecting colon cancer. Called Shield, the noninvasive test was authorized for use by people aged 45 and older with an “average risk” of the...
MedBen Debit Card Offers Savings and Convenience
Offering your plan members a flexible spending account (FSA) option is not only an effective way to help them lower their health care spend (qualified purchases are made using tax-free dollars), but by adding a MedBen debit card, it's a convenient way to do it! The...
FTC Accuses Major PBMs of Overcharging Clients
In an interim report released on July 9, the Federal Trade Commission charges major pharmacy benefit managers of engaging in business practices designed to benefit their own bottom lines at the expense of clients. The FTC report, subtitled "The Powerful Middlemen...
Finding the Right Reimbursement Balance by Exploring the “Alternatives”
A new survey on health and benefit strategies for 2025 finds that one-third of large employers will offer an "alternative medical plan" to steer employees to quality, cost-effective care. At MedBen, nearly half of our clients have implemented alternative reimbursement...
Nearly Half of U.S. Cancer Deaths Linked to Modifiable Risk Factors
According to a study by the American Cancer Society, four out of ten cancer cases and almost half of cancer deaths in U.S. adults aged 30 and older are associated with modifiable risk factors. In 2019, these factors were linked to over 700,000 new cancer cases and...
What Is Subrogation, and Why Does It Matter to Your Plan?
If one of your plan members is injured as the result of an accident, it's possible that subrogation may be necessary. Subrogation is a recovery process in which medical claim costs resulting from the injury, initially covered by the employer, are reimbursed from a...